Texas Oncology - Austin-USOR Texas Oncology - Austin ( Site 8003) — Austin, Texas

Texas Oncology - Austin-USOR Texas Oncology - Austin ( Site 8003) is a clinical research site located in Austin, Texas, United States 78731.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Texas Oncology - Austin-USOR Texas Oncology - Austin ( Site 8003) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Endometrial Neoplasms.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Austin

Browse all research sites in Texas · View every site in Austin

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology - Austin-USOR Texas Oncology - Austin ( Site 8003)?

Texas Oncology - Austin-USOR Texas Oncology - Austin ( Site 8003) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology - Austin-USOR Texas Oncology - Austin ( Site 8003) conducted?

Texas Oncology - Austin-USOR Texas Oncology - Austin ( Site 8003) has 1 clinical trials on record, with 1 currently active. Their work covers Endometrial Neoplasms.

Is Texas Oncology - Austin-USOR Texas Oncology - Austin ( Site 8003) accredited by Crixeo Clinical Trials?

Texas Oncology - Austin-USOR Texas Oncology - Austin ( Site 8003) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology - Austin-USOR Texas Oncology - Austin ( Site 8003)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.